Projects per year
Organization profile
Organisation Profile
International and National Collaboration
Publications and projects within past five years.
Profiles
Osmo Antikainen
- Division of Pharmaceutical Chemistry and Technology - University Lecturer
Person: U3 Research and teaching staff
Vimalkumar Balasubramanian
- Division of Pharmaceutical Chemistry and Technology - Postdoctoral Researcher
- Nanomedicines and Biomedical Engineering
- Staff Services - Title of Docent
Person: U2 Teaching and research staff, Teaching and research personnel
Gustav Boije af Gennäs
- Division of Pharmaceutical Chemistry and Technology - University Researcher
- Drug Research Program
Person: U3 Research and teaching staff, UH
Mael Antton Briand
- Division of Pharmaceutical Chemistry and Technology - Doctoral Student
- Doctoral Programme in Chemistry and Molecular Sciences
Person: U1 Research and teaching staff
Research Units
Nanomedicines and Biomedical Engineering
Division of Pharmaceutical Chemistry and Technology
Organisational unit: Research Group
Pharmaceutical biophysics group
Division of Pharmaceutical Chemistry and Technology
Organisational unit: Research Group
Pharmaceutical Design and Discovery group
Division of Pharmaceutical Chemistry and Technology
Organisational unit: Research Group
Tiina Sikanen / Chemical Microsystems Lab
Division of Pharmaceutical Chemistry and Technology
Organisational unit: Research Group
Projects
Immunomodulation: towards effective and safe inflammatory bowel disease therapy
01/05/2020 → 30/04/2023
Project: Research project
PreMeDosE: Precision Medicine via Diagnostic Enzyme Activity Testing
01/01/2020 → 30/06/2021
Project: Research project
EMiRa: Enzyme microreactor technology for identification of acute drug-drug interactions in vitro
Haapala, M., Sikanen, T. & Tähkä, S.
01/01/2020 → 31/12/2021
Project: Research project
PRINTOX: 3D-printed organ-on-a-chip platforms for in vitro toxicity screening of xenobiotics
Sikanen, T., Haapala, M. & Piironen, K.
01/09/2019 → 31/08/2023
Project: Research project
Orally delivered immunomodulatory cytokines reprogram macrophages for inflammatory bowel disease therapy
01/09/2019 → 31/08/2022
Project: Research project
Publications
A Biomimetic 3D-Self-Forming Approach for Microvascular Scaffolds
Zhang, L., Xiang, Y., Zhang, H., Cheng, L., Mao, X., An, N., Zhang, L., Zhou, J., Deng, L., Zhang, Y., Sun, X., Santos, H. A. & Cui, W., 6 May 2020, In : Advanced Science. 7, 9, 10 p., 1903553.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
Cheng, R., Liu, L., Xiang, Y., Lu, Y., Deng, L., Zhang, H., Santos, H. A. & Cui, W., Feb 2020, In : Biomaterials. 232, 17 p., 119706.Research output: Contribution to journal › Review Article › Scientific › peer-review
Open Access
File
A Focus Group Study about Oral Drug Administration Practices at Hospital Wards-Aspects to Consider in Drug Development of Age-Appropriate Formulations for Children
Rautamo, M., Kvarnström, K., Siven, M., Airaksinen, M., Lahdenne, P. & Sandler, N., Feb 2020, In : Pharmaceutics. 12, 2, 13 p., 109.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
Costa, C., Liu, Z., Martins, J. P., Correia, A., Rahikkala, A. T. A., Li, W., Seitsonen, J., Ruokolainen, J., Hirvonen, S-P., Aguiar- Ricardo, A., Corvo, M. L. & Santos, H. A., 27 May 2020, In : Biomaterials Science. 8, p. 8 3270 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
A platform for studying the transfer of Chlamydia pneumoniae infection between respiratory epithelium and phagocytes
Kortesoja, M., Trofin, R. E. & Hanski, L., Apr 2020, In : Journal of Microbiological Methods. 171, 9 p., 105857.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Activities
Ministry of Economic Affairs and Employment (External organisation)
Jari Yli-Kauhaluoma (Expert)1 May 2020 → 31 Dec 2020
Activity: Membership types › Membership or other role in national/international committee, council, board
Journal of Medicinal Chemistry (Journal)
Jari Yli-Kauhaluoma (Reviewer)10 Mar 2020
Activity: Publication peer-review and editorial work types › Peer review of manuscripts
Member of doctoral thesis committee: New bioorthogonal radiolabeling strategies for tracking tumor infiltrating lymphocytes and their progeny in mouse models of metastatic melanoma
Jari Yli-Kauhaluoma (Member of thesis committee / follow-up group)18 Mar 2020 → …
Activity: Examination types › Member of doctoral thesis committee / follow-up group
Targeted nanoparticles for cardiac tissue regeneration
Giulia Torrieri (Speaker)15 Jan 2020 → 17 Jan 2020
Activity: Talk or presentation types › Invited talk
Frontiers in Bioengineering and Biotechnology (Journal)
Wei Li (Reviewer)2020 → …
Activity: Publication peer-review and editorial work types › Peer review of manuscripts
Prizes
2014 Control Release Society Outstanding Oral Drug Delivery Paper Award
Hongbo Zhang (Recipient), 16 Jul 2014
Prize: Prizes and awards
2016 ACADEMY OF FINLAND AWARD FOR SOCIAL IMPACT
Hélder A. Santos (Recipient), 24 Nov 2016
Prize: Prizes and awards
2019 OrD Trainee Video Competition
João Pedro Martins (Recipient), 1 Mar 2019
Prize: Prizes and awards
3 min thesis presentation competition award
Jukka Saarinen (Recipient), 19 Aug 2015
Prize: Prizes and awards
Academy of Finland postdoctoral researcher
Tiina Sikanen (Recipient), Aug 2011
Prize: Prizes and awards
Datasets
Artificial cell membranes on microchips for affinity chromatography
Boije af Gennäs, G. (Creator), Academy of Finland, 1 Oct 2016
Dataset
Press / Media
-University of Helsinki: Advanced viral nanovaccine for cancer immunotherapy
18/12/2019
1 item of Media coverage
Press/Media: Press / Media
Advanced viral nanovaccine for cancer immunotherapy
17/12/2019
4 items of Media coverage
Press/Media: Press / Media
-UNIVERSITY OF HELSINKI: Personalized nanovaccines are safe, well tolerated, and have an effect in melanoma
14/06/2019
1 item of Media coverage
Press/Media: Press / Media